发明授权
US07256253B2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components 失效
通过与血液成分缀合,保护内源性治疗肽免受肽酶活性的影响

Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
摘要:
A secretin or secretin derivative protected against peptidase activity. The secretin or derivative comprises a peptidic sequence and a reactive group selected from the group consisting of succinimidyl and maleimido groups capable of reacting with an amino group, hydroxyl group or thiol group on a blood component to form a stable covalent bond. The reactive group is attached at a position along the peptidic sequence that provides, when conjugated to a blood component, a higher stability against peptidase degradation than the unconjugated secretin or derivative, and therefore an increased maintenance of the therapeutic activity compared to the unconjugated secretin or derivative. Such a compound is thus effective to provide a source of secretin having a high stability against peptidases. A method for synthesizing such a compound is also described.
信息查询
0/0